Characteristics of patients targeted in intervention
| Frequency (%) from total targeted cohort (n=13 968) | |
| Male | 8117 (58.11) |
| Age ≤49 years | 1464 (10.48) |
| Age 50–64 years | 2133 (15.27) |
| Age 65–79 years | 4522 (32.37) |
| Age 80 years and older | 5849 (41.87) |
| Opioid therapy for longer than 3 months | 8699 (62.28) |
| High dose (over recommended maximum dose of 40 mg OME per day) | 4581 (32.80) |
| Very high dose (opioid dose above 100 mg OME per day) | 1376 (9.85) |
| Coprescribed a benzodiazepine | 3940 (28.21) |
| Geographic residence | % |
| Cities | 49.37 |
| Inner regional | 36.09 |
| Outer regional | 13.44 |
| Remote | 1.09 |
OME, oral morphine equivalent.